Your browser doesn't support javascript.
loading
Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn's Disease Is Determined by Their Concentration.
Edlund, Helena; Steenholdt, Casper; Ainsworth, Mark A; Goebgen, Eva; Brynskov, Jørn; Thomsen, Ole Ø; Huisinga, Wilhelm; Kloft, Charlotte.
Affiliation
  • Edlund H; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, Germany.
  • Steenholdt C; Graduate Research Training Program PharMetrX, Berlin, Germany.
  • Ainsworth MA; Department of Gastroenterology, Herlev Hospital, Herlev, Denmark.
  • Goebgen E; Department of Gastroenterology, Herlev Hospital, Herlev, Denmark.
  • Brynskov J; Department of Gastroenterology, Herlev Hospital, Herlev, Denmark.
  • Thomsen OØ; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, Germany.
  • Huisinga W; Department of Gastroenterology, Herlev Hospital, Herlev, Denmark.
  • Kloft C; Department of Gastroenterology, Herlev Hospital, Herlev, Denmark.
AAPS J ; 19(1): 223-233, 2017 01.
Article in En | MEDLINE | ID: mdl-27739011
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Crohn Disease / Infliximab / Models, Biological / Antibodies Type of study: Guideline / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: AAPS J Year: 2017 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Crohn Disease / Infliximab / Models, Biological / Antibodies Type of study: Guideline / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: AAPS J Year: 2017 Document type: Article